• Thu, May 5, 2022
Drew Ranieri Maintained (AVNS) at Sell with Decreased Target to $33 on, May 5th, 2022
Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $36 to $33 on, May 5th, 2022.
Drew has made no other calls on AVNS in the last 4 months.
There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Drew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Drew
- Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $41 on, Thursday, February 24th, 2022